Current treatments for sudden deafness (SD) include steroid, vasodilator, hemodilution, stellate ganglion block, and hyperbaric oxygen (HBO2) therapy. Two reports showed the acupuncture treatment was also effective for SD. In order to strengthen the therapeutic efficiency of SD, we used a combined treatment of acupuncture, steroid, and HBO2 in 35 eases and compared the extent of hearing loss before and after the combined treatment. Between June 1998 and December 2006, 35 cases of SD were collected in this retrospective study and all received a combined treatment of acupuncture, steroid and HBO2. The acupuncture treatment was carried out at the traditional acupuncture points over head and hand. The steroid therapy was given with oral prednisolone at a dosage of 1mg/kg/day for 7 days. The HBO2 therapy was conducted at 2.5 ATA of 100% oxygen, 120 minutes for an average of 8 sessions in our multi-place hyperbaric chamber. Before & after the combined treatment, the pure tone audiogram was taken to evaluate the extent of hearing loss. After the combined treatment, 30 of 35 cases (85.7%) showed an improvement in hearing loss from 75.9±24.9 dB (before) to 53.9±32.2 dB (after), p<0.01. Nineteen of 35 cases (54.3%) had marked improvement in hearing loss (≧20 dB). In five cases with the period from onset to treatment for those ≧3 weeks, there were only an improvement for an average of 2.36 dB in hearing loss as compared to 25.1 dB for those ≧1 week and <3 weeks (n=8), and 25.3 dB for those <1 week (n=22). From these results, we suggest that this combined treatment of acupuncture, steroid and HBO2 may be a useful management for SD. The early treatment for those periods <3 weeks from onset of SD seems to have a better clinical outcome.
Current treatments for sudden deafness (SD) include steroid, vasodilator, hemodilution, stellate ganglion block, and hyperbaric oxygen (HBO2) therapy. Two reports showed the acupuncture treatment was also effective for SD. In order to strengthen the therapeutic efficiency of SD, we used a combined treatment of acupuncture, steroid, and HBO2 in 35 eases and compared the extent of hearing loss before and after the combined treatment. Between June 1998 and December 2006, 35 cases of SD were collected in this retrospective study and all received a combined treatment of acupuncture, steroid and HBO2. The acupuncture treatment was carried out at the traditional acupuncture points over head and hand. The steroid therapy was given with oral prednisolone at a dosage of 1mg/kg/day for 7 days. The HBO2 therapy was conducted at 2.5 ATA of 100% oxygen, 120 minutes for an average of 8 sessions in our multi-place hyperbaric chamber. Before & after the combined treatment, the pure tone audiogram was taken to evaluate the extent of hearing loss. After the combined treatment, 30 of 35 cases (85.7%) showed an improvement in hearing loss from 75.9±24.9 dB (before) to 53.9±32.2 dB (after), p<0.01. Nineteen of 35 cases (54.3%) had marked improvement in hearing loss (≧20 dB). In five cases with the period from onset to treatment for those ≧3 weeks, there were only an improvement for an average of 2.36 dB in hearing loss as compared to 25.1 dB for those ≧1 week and <3 weeks (n=8), and 25.3 dB for those <1 week (n=22). From these results, we suggest that this combined treatment of acupuncture, steroid and HBO2 may be a useful management for SD. The early treatment for those periods <3 weeks from onset of SD seems to have a better clinical outcome.